Open Access

Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells

  • Authors:
    • Jing Jin
    • Yilong Zhu
    • Fei Sun
    • Zhifei Chen
    • Shuang Chen
    • Yiquan Li
    • Wenjie Li
    • Min Li
    • Chuanxin Cui
    • Yingli Cui
    • Xunzhi Yin
    • Shanzhi Li
    • Jin Zhao
    • Guo Yan
    • Xiao Li
    • Ningyi Jin
  • View Affiliations

  • Published online on: September 20, 2018     https://doi.org/10.3892/ol.2018.9470
  • Pages: 6275-6282
  • Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The effect of the combination of a recombinant adenovirus (ATV) expressing a specific apoptin protein and cisplatin on human lung cancer cells (A549 cells) was determined. The inhibitory effects of ATV and cisplatin, ATV alone, or cisplatin alone on the migration and invasion of A549 cells were evaluated in vitro using cell proliferation, wound healing, Transwell migration and Matrigel invasion assays. The tumor inhibition effect on A549 cells in vivo was assessed by observing the tumor growth and survival rate of nude mice with subcutaneous tumor xenografts grown from implanted A549 cells after treatment with ATV, cisplatin, or ATV combined with cisplatin. The proliferation (P<0.01), migration (P<0.01), and invasion (P<0.01) on A549 cells was suppressed significantly by ATV, cisplatin, and ATV and cisplatin, in a dose‑ and time‑dependent manner. The inhibition of tumor growth in transplanted nude mice in the ATV combined with cisplatin group was significantly higher than that displayed in the other groups, and the survival rate of the combined treatment group was significantly higher than that of the group treated with cisplatin alone. The results indicated that the combined application of ATV and cisplatin could reduce toxicity and showed a synergistic effect in reducing tumor growth and increasing survival. Thus, there is a potential research value in treating tumors using the combination of ATV and cisplatin, which provides a foundation for future preclinical studies on this antitumor treatment.
View Figures
View References

Related Articles

Journal Cover

November-2018
Volume 16 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jin J, Zhu Y, Sun F, Chen Z, Chen S, Li Y, Li W, Li M, Cui C, Cui Y, Cui Y, et al: Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells. Oncol Lett 16: 6275-6282, 2018
APA
Jin, J., Zhu, Y., Sun, F., Chen, Z., Chen, S., Li, Y. ... Jin, N. (2018). Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells. Oncology Letters, 16, 6275-6282. https://doi.org/10.3892/ol.2018.9470
MLA
Jin, J., Zhu, Y., Sun, F., Chen, Z., Chen, S., Li, Y., Li, W., Li, M., Cui, C., Cui, Y., Yin, X., Li, S., Zhao, J., Yan, G., Li, X., Jin, N."Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells". Oncology Letters 16.5 (2018): 6275-6282.
Chicago
Jin, J., Zhu, Y., Sun, F., Chen, Z., Chen, S., Li, Y., Li, W., Li, M., Cui, C., Cui, Y., Yin, X., Li, S., Zhao, J., Yan, G., Li, X., Jin, N."Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells". Oncology Letters 16, no. 5 (2018): 6275-6282. https://doi.org/10.3892/ol.2018.9470